Skip to content

Ketoprofen Cataplasms for Pain Relief in Patients with Knee Osteoarthritis:a Randomized Controlled Trial

Ketoprofen Cataplasms for Pain Relief in Patients with Knee Osteoarthritis:a Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092881
Enrollment
Unknown
Registered
2024-11-25
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis

Interventions

Group B:Oral nonsteroidal anti-inflammatory drugs (NSAIDs)
Group C:Ketoprofen cataplasms combined with oral nonsteroidal anti-inflammatory drugs (NSAIDs).

Sponsors

The Second Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1)Patients agree to participate in this study and sign a written informed consent form; (2)Aged 40~75 years old; (3) 18kg/m240mm; (5)Without the history of bleeding,asthma,severe heart\hepatic\renal insufficiency, non-steroida allergy, etc.; (6)The drugs used in experimental group and control group are contained in the drug list specified in this study.

Exclusion criteria

Exclusion criteria: (1)Previous treatment that may affect the drugs efficacy; (2)With open wounds, scars, or ulcers in the area where the gel patch is used; (3)With fractures, dislocations, etc.; with severe diseases such as tumors, cardiovascular and cerebrovascular diseases, and hematopathy,with mental illness and communication disorders that efficacy cannot be determined.Additionally pain and mobility disorder related to other conditions(eg,internal organs lesion,cardiovascular and cerebrovascular diseases ) .Allergy to this class of non-steroidal drugs; (4)Pregnant, Lactating women,or women of childbearing age who are preparing to conceive; (5)With other conditions that the researchers deems inappropriate to participate in this study.

Design outcomes

Primary

MeasureTime frame
Western Ontario and McMaster University Osteoarthritis Index;

Secondary

MeasureTime frame
Visual Analogue Scale ;Percentage of subjects with WOMAC pain subscale decreased from baseline by =30%, =50%, =70%, and =90% ;Proportion of subjects responding to OMERACT-OARSI;Lysholm Knee Scoring Scale;Paracetamol tablet usage;Comfort of cataplasms;Satisfaction surveys;

Countries

China

Contacts

Public ContactHui Li

The Second Xiangya Hospital of Central South University

yinaimeireh@163.com+86 132 0316 5603

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026